{"id":"https://openalex.org/W35046255","doi":"https://doi.org/10.18907/jjsre.34.1_95_2","title":"[Stage \u2163 HER2-Positive Breast Cancer That Showed Complete Response for Over One Year after Discontinuation of Anti-HER2 Therapy-A Case Report].","display_name":"[Stage \u2163 HER2-Positive Breast Cancer That Showed Complete Response for Over One Year after Discontinuation of Anti-HER2 Therapy-A Case Report].","publication_year":2021,"publication_date":"2021-12-01","ids":{"openalex":"https://openalex.org/W35046255","doi":"https://doi.org/10.18907/jjsre.34.1_95_2","mag":"35046255","pmid":"https://pubmed.ncbi.nlm.nih.gov/35046255"},"language":"ja","primary_location":{"id":"pmid:35046255","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35046255","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Case Reports"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076456138","display_name":"Hirofumi Terakawa","orcid":"https://orcid.org/0000-0002-9475-190X","observed_orcids":["https://orcid.org/0000-0002-9475-190X"]},"institutions":[{"id":"https://openalex.org/I4405258002","display_name":"Kurobe City Hospital","ror":"https://ror.org/05xqrc755","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405258002"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirofumi Terakawa","raw_affiliation_strings":["Dept. of Surgery, Kurobe City Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Surgery, Kurobe City Hospital","institution_ids":["https://openalex.org/I4405258002"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041731809","display_name":"Takuya Ogaito","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takuya Ogaito","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5142948346","display_name":"Koji Okamoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koji Okamoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124206388","display_name":"Sosuke Shima","orcid":"https://orcid.org/0009-0000-2148-2035","observed_orcids":["https://orcid.org/0009-0000-2148-2035"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sosuke Shima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028909035","display_name":"Kento Terasaki","orcid":"https://orcid.org/0009-0006-9751-3647","observed_orcids":["https://orcid.org/0009-0006-9751-3647"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kento Terasaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031233535","display_name":"\u5927\u661f\u9686\u53f8","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroyuki Tanaka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5142534549","display_name":"Masashi Hashimoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masashi Hashimoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071020024","display_name":"Ryosuke Zaimoku","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryosuke Zaimoku","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5142508905","display_name":"Ryohei Takei","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryohei Takei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009122466","display_name":"Itsuro Terada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Itsuro Terada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054345103","display_name":"Yuji Tsukioka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuji Tsukioka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110669167","display_name":"Masato Kiriyama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masato Kiriyama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":1.716e-05,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":"13","first_page":"1559","last_page":"1560"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9810000061988831},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9449999928474426},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8849999904632568},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":1.0},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8410000205039978},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.6129999756813049},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.9290000200271606},{"id":"https://openalex.org/keywords/invasive-ductal-carcinoma","display_name":"invasive ductal carcinoma","score":0.8450000286102295},{"id":"https://openalex.org/keywords/scirrhous-carcinoma","display_name":"scirrhous carcinoma","score":0.7749999761581421},{"id":"https://openalex.org/keywords/drug-hypersensitivity","display_name":"drug hypersensitivity","score":0.6790000200271606},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.3540000021457672}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4976995289325714},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.40221279859542847}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:35046255","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35046255","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"Case Reports"},{"id":"mag:35046255","doi":"https://doi.org/10.18907/jjsre.34.1_95_2","is_oa":false,"landing_page_url":"https://ci.nii.ac.jp/naid/110009328032","pdf_url":null,"source":{"id":"https://openalex.org/S4306553164","display_name":"\u6c17\u7ba1\u652f\u5b66 : \u65e5\u672c\u6c17\u7ba1\u652f\u7814\u7a76\u4f1a\u96d1\u8a8c","issn_l":"0287-2137","issn":["0287-2137"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u6c17\u7ba1\u652f\u5b66 : \u65e5\u672c\u6c17\u7ba1\u652f\u7814\u7a76\u4f1a\u96d1\u8a8c","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2754658727","https://openalex.org/W4409913854","https://openalex.org/W3130358024","https://openalex.org/W2980593737","https://openalex.org/W2977917008","https://openalex.org/W2087854828","https://openalex.org/W2522070725","https://openalex.org/W4403129765","https://openalex.org/W2103355045","https://openalex.org/W2004083039"],"abstract_inverted_index":{"A":[0],"75-year-old":[1],"woman":[2],"with":[3,26,66,82],"a":[4,53,105,126,156],"left":[5,23,30,32,35,40],"breast":[6,9,24,75,152],"mass":[7],"on":[8],"cancer":[10,25,153],"screening":[11],"was":[12,64,80,113,129,146],"referred":[13],"to":[14,28,91],"our":[15],"hospital":[16],"for":[17,131,148],"detailed":[18],"evaluation.":[19],"Further":[20],"examination":[21],"revealed":[22,57],"metastases":[27],"the":[29,100],"axilla,":[31],"parasternal":[33],"region,":[34],"supraclavicular":[36],"fossa,":[37],"mediastinum,":[38],"and":[39,62,85,93,97,111,125,134,144,154],"hilar":[41],"lymph":[42],"nodes,":[43],"as":[44,46],"well":[45],"multiple":[47],"lung":[48],"metastases.":[49],"Histopathological":[50],"evaluation":[51,121],"of":[52],"needle":[54],"biopsy":[55],"specimen":[56],"invasive":[58],"ductal":[59],"carcinoma(scirrhous":[60],"type),":[61],"she":[63,88],"diagnosed":[65],"Stage":[67,149],"\u2163":[68,150],"human":[69],"epidermal":[70],"growth":[71],"factor":[72],"receptor":[73],"2(HER2)-positive":[74],"cancer.":[76],"Following":[77],"diagnosis,":[78],"treatment":[79,112,123,164],"initiated":[81],"trastuzumab,":[83],"pertuzumab,":[84],"docetaxel;":[86],"however,":[87],"developed":[89],"hypersensitivity":[90],"docetaxel":[92],"received":[94],"only":[95],"trastuzumab":[96,143],"pertuzumab":[98,145],"after":[99,108,115,122,163],"second":[101],"course.":[102],"We":[103,137],"observed":[104],"complete":[106,127,157],"response":[107,128,158],"3":[109],"courses,":[110],"discontinued":[114],"13":[116],"courses.":[117],"She":[118],"underwent":[119],"regular":[120],"discontinuation,":[124],"maintained":[130,161],"1":[132],"year":[133],"6":[135],"months.":[136],"conclude":[138],"that":[139,155],"combination":[140],"therapy":[141],"comprising":[142],"effective":[147],"HER2-positive":[151],"could":[159],"be":[160],"even":[162],"discontinuation.":[165]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}